“We are delighted to welcome Don to our executive team,” said Greg Kunst, Aurion’s CEO. “Don’s track record of strategic and operational financial leadership, coupled with his extensive experience as ...

The "Crown" logo, PanOxyl and Blue Lizard are registered trademarks of Crown Laboratories, Inc. SkinPen and StriVectin are registered trademarks of Bellus Medical, LLC and StriVectin Operating Company ...

JOHNSON CITY, Tenn. - Crown Laboratories, Inc., a global skincare company, has finalized its acquisition of biotechnology ...

Nashville-based aesthetics biotech company Revance Therapeutics announced Wednesday that a planned merging with Johnson City, ...

AbbVie Inc . (NYSE:ABBV), currently trading at $190.14, has demonstrated resilience and strategic foresight as it navigates the loss of exclusivity for its blockbuster drug Humira. The ...

No sector is left unchanged by the power of AI and digital modeling, and Biotech is no exception. This is because biology is by far the most “messy” of hard sciences. Chemistry or physics can deal ...

Biotech stocks are companies that use living organisms to make drugs and vaccines. Often, they merge cutting-edge technology with new findings in molecular science and virology to treat life ...

AbbVie (ABBV) stock was one of the top gainers in the S&P 500 Friday morning as the biotech firm posted better ... In addition, AbbVie sees aesthetics revenues through 2029 to be in a high-single ...

Mizuho Securities analyst Uy Ear has maintained their neutral stance on RVNC stock, giving a Hold rating on January 17.Invest with Confidence: ...

Newport Beach-based Elevai last month underwent a company reorganization, including switching parent companies and changing the company’s name from Elevai Labs to PMGC Holdings Inc.

The complaint outlined that AbbVie provided travel tickets and hotel accommodation for extravagant pleasure trips under the guise of conferences-Aesthetics and Anti-aging Medicine World Congress 2024, ...